Renflexis for Crohn's Disease User Reviews
- Anonymous
- Taken for less than 1 month
- June 21, 2023
"This medication totally debilitated me. It’s a generic drug that should be taken off the market."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Crohn's Disease
Symptoms and treatments
Medicine.com guides (external)
More about Renflexis (infliximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Patient resources
- Renflexis drug information
- Renflexis (Infliximab Intravenous) (Advanced Reading)
- Renflexis (Infliximab-abda Intravenous) (Advanced Reading)
Other brands
Remicade, Inflectra, Avsola, Zymfentra, Ixifi
Professional resources
Other brands
Remicade, Inflectra, Avsola, Zymfentra
"I started with Remicade/Inflectra in 2019 when my Crohn's disease became super activated in graduate school. Both of those helped. I was switched by my provider to Renflexis this past September due to cost, and my last two infusions were with Renflexis. I have noticed an improvement over Inflectra. Bowel movement frequency has decreased, and the looseness of stools has improved - and I have a very short gut due to two bowel excisions and resections. I'm pretty excited about this improvement. I was worried initially and reassured that it is biosimilar. It may be, but whatever difference Renflexis has, it's working better for me!"